In the spotlight of Viridian Capital Advisors’ latest Weekly Valuation Report are 16 Tier 2 and 3 U.S. cultivation and retail cannabis companies, each boasting market capitalizations between $10 million and $200 million. This deep dive into the sector, amidst a notably quiet week for equity issues, brings to the forefront the newly available 2025 analyst consensus estimates, illuminating the evolving valuation trends within this dynamic market. The report provides an insightful examination of the financial landscape for these cannabis enterprises, offering key observations on their current and…
